... atopic dermatitis (AD), the company said in a statement. ... Pfizer intends to share these data with the US Food and Drug Administration (FDA) and other ...
Read more: Pfizer's phase-III Jade trial shows positive results for moderate-to-severe atopic dermatitisa ...